Filter
220
Text search:
FDA
Featured
Recommendations
21
New Publications
30
Language
Document type
No document type
103
Guidelines
63
Studies & Reports
27
Manuals
7
Fact sheets
7
Strategic & Response Plan
6
Training Material
4
Resource Platforms
2
Situation Updates
1
Countries / Regions
India
8
Russia
8
Latin America and the Carribbean
7
Ghana
6
Philippines
4
Syria
4
South Africa
4
Ecuador
4
Uganda
3
Sudan
3
Yemen
3
Middle East and North Africa
3
South–East Asia Region
3
Western and Central Europe
3
Eastern Europe
3
Congo, Democratic Republic of
2
USA
2
Ethiopia
2
South Sudan
2
Brazil
2
Colombia
2
Myanmar / Burma
2
Asia
2
Global
2
Nigeria
1
Zimbabwe
1
Iraq
1
Jordan
1
Germany
1
Kenya
1
Tanzania
1
Thailand
1
Argentina
1
Bolivia
1
Chile
1
Paraguay
1
Africa
1
Venezuela
1
Kazakhstan
1
France
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
57
Clinical Guidelines
26
Pharmacy & Technologies
12
Women & Child Health
5
Public Health
4
Key Resources
3
Toolboxes
COVID-19
47
Mental Health
30
TB
25
HIV
22
Pharmacy
13
AMR
12
Specific Hazards
7
Ebola & Marburg
4
Rapid Response
4
Planetary Health
4
NTDs
4
Refugee
3
NCDs
3
Malaria
2
2.0 Rapid Response
2
Cholera
1
Conflict
1
Natural Hazards
1
Zika
1
Global Health Education
1
Caregiver
1
The potential for terrorist use of chemical agents is a noted concern highlighted by the Tokyo sarin gas attacks of 1995. The events of September 11, 2001, increased congressional attention towards reducing the vulnerability of the United States to such unconventional attacks. The
possibility that
...
Руководство ВОЗ по политике и практике информирования о рисках при чрезвычайных ситуациях (ИРЧС)
Anxiety disorders
Chapter F.3
Including Therapeutic Food, Dietary Vitamin and Mineral Supplementation - 2nd edition
Trastornos de ansiedad
Capítulo F.1
Edición en español
Editor: Matías Irarrázaval
Traducción: Matías Irarrázaval y María Tatiana Estefan
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent
...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i
...
20 February 2013
Update on 2004 Background Paper (Written by Saloni Tanna)
Priority Medicines for Europe and the World "A Public Health Approach to Innovation"
The objective of the study was the validation and implementation of GeneXpert MTB/RIF for routine use in the rapid detection of tuberculosis and sensitivity to rifampicin in clinical samples; for this, 1592 respiratory samples were collected and analyzed in the laboratory of Instituto Nacional de In
...
UNAIDS 2016 / Meeting Report
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with infections and could potentially
extend the lifespan of current narrow- spectrum antimicrobials. Althoug
...
Drug Distribution and Control: Preparation and Handling
This Technical Assistance Bulletin is intended to assist pharmacists in the extemporaneous compounding of non-sterile drug products for individual patients. Included in this document is information on facilities and equipment, ingredient
...
This document is part of the process for improving the quality of care in family planning. Medical eligibility criteria for contraceptive use (MEC), the first edition of which was published in 1996, prsents current World Health Organization (WHO) guidance on the safety of various contraceptive e-
m
...
